PamChip® Microarrays and PamStation® Instruments -A Novel Platform to Support Kinase and Kinase Inhibitor Research
6 Feb 2013
PamGene microarray technology was first presented in 2001 for nucleic acid applications. Today, the platform is among others used for kinase and kinase inhibitor drug research. Read this application note to learn how the technology is used to find peptides for translational research and patient prognosis, diagnosis and treatment response prediction.